Who makes ETD002 - single dose?

ETD002 - single dose is developed by Enterprise Therapeutics Ltd.

What development phase is ETD002 - single dose in?

ETD002 - single dose is in Phase 1.

Last reviewed 2026-04-19 · How we verify

ETD002 - single dose

Enterprise Therapeutics Ltd · Phase 1 active Small molecule

At a glance

Generic name	ETD002 - single dose
Sponsor	Enterprise Therapeutics Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ETD002 - single dose CI brief — competitive landscape report
ETD002 - single dose updates RSS · CI watch RSS
Enterprise Therapeutics Ltd portfolio CI